T. Rowe Price's Wenli Zheng discusses how their China Evolution Equity Strategy arguably has a a unique design among China equity strategies
If an entity has a progressive approach to human rights, it is more likely to be able to maintain its social license to operate, says BlueBay AM's My-Linh Ngo
As market dynamics twist and turn, a flexible approach delivers results according to T. Rowe Price's Arif Husain
2021 was a record year for dividends around the globe Our EMEA ETF Investment Strategy team believes that while Chinese equities may need to consolidate in the short-term, the recovery since the March 2022 low remains on track.
An asset allocation perspective during a regime shift: focus on policy, inflation and growth
Investors should look beyond ESG-labelled debt and at opportunities like unlabelled green bonds and climate leader bonds